FDA finally analyzed its own youth tobacco data

Article excerpt

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. A lot of people had reactions, comments, and theories regarding Lizzy’s story yesterday on the mystery patient who received retatrutide. What’s undeniable, though, is the strength of Lizzy’s reporting. Read the rest…